#14: Blastomycosis in 64 Wisconsin Children: Unanticipated Infection Risk and Severity in Urban Residents

2021 ◽  
Vol 10 (Supplement_2) ◽  
pp. S8-S8
Author(s):  
Jaimee M Hall ◽  
Peter L Havens ◽  
Errin A Mitchell ◽  
Gabriel N De Vela ◽  
Lauren L Titus ◽  
...  

Abstract Background Blastomycosis is an endemic mycosis of immunocompetent individuals, typically seen after exposure to wooded areas near rivers, lakes, and streams in rural locations, and often not considered a disease of urban environments. Disease can be isolated to lung, or disseminate to skin, bone, or central nervous system. Factors influencing disease acquisition and severity in children are unknown. Methods We analyzed acquisition risk factors and disease characteristics of blastomycosis in children treated at a tertiary care center from 1998–2018 to identify exposure source and measure disease severity, to identify cases without “typical exposure”, and to measure the effect of race on disease severity. Results Of 64 children, median age was 13.3 years, 72% were male, 38% resided in urban counties, and 50% had typical environmental exposure. Isolated pulmonary infection occurred in 33 (52%). The remaining children had evidence of dissemination including skin (N=13), bone (N=16; 7 clinically silent), and central nervous system (N=7; 3 clinically silent). Infection was moderate/severe in 19 (30%). Two children (3%) died. 79% of children with moderate/severe disease (p=0.008) and 71% of urban children (p=0.007) had no typical environmental exposure. Comparing children from urban counties to other residences, 63% versus 5% were black (p<0.001) and 71% versus 35% developed extrapulmonary dissemination (p=0.006). Moderate/severe disease occurred in 7/17 (42%) black and 12/47 (26%) children of other race (p=0.23). Conclusions Blastomycosis, endemic in urban children in the absence of typical exposure history, has frequent, sometimes clinically silent, extrapulmonary dissemination, with a trend toward more severe disease in black children.

Author(s):  
Mukesh Kumar ◽  
Mukta Meel ◽  
Nikita Choudhary ◽  
Ashok Singh ◽  
Kusum Mathur

Abstract Background Nonneoplastic cysts of brain are a diverse group of benign lesions with variable etiopathogenesis. Due to different site and histogenesis, these lesions have wide clinicopathologic spectrum. Objective The study was performed to evaluate epidemiology and clinicopathologic spectrum of nonneoplastic central nervous system (CNS) cysts highlighting the role of histopathology in the diagnosis as well as to compare the data with other institution’s data available in literature. Materials and Methods All nonneoplastic CNS cysts reported from January 2013 to June 2020 in the Department of Pathology of Sawai Man Singh Medical College, Jaipur, were retrieved and reviewed. The data were evaluated for age, site, cyst wall lining, nature of cyst contents, and location (intracranial and spinal), using SPSS software version 20.0. Results A total of 255 cases were reviewed with an incidence of 4.96% and an age range of 2 to 74 years with slight male preponderance. Among them there were 157, 34, 26, 24, and 2 cases of epidermoid, arachnoid, dermoid, colloid, and glioependymal cysts, respectively, and 1 case of perineural cyst. Infective cysts were much less common than noninfective cysts, accounting for two cases of neurocysticercosis and hydatid cysts each. All cyst types mainly presented with signs and symptoms of a mass lesion. Conclusion Nonneoplastic cyst mainly presented like a CNS mass lesion with overlapping clinical features, and image finding revealing the key role of histopathological analysis. Epidermoids were the most common type of these cysts in the present series followed by the arachnoid cysts.


2021 ◽  
Vol 8 ◽  
pp. 2333794X2110227
Author(s):  
Jocelyn Y. Ang ◽  
Nirupama Kannikeswaran ◽  
Katherine Parker ◽  
Eric McGrath ◽  
Nahed Abdel-Haq ◽  
...  

Background. The COVID-19 pandemic has shed light on communities of racial/ethnic minority groups in the US where long-standing health issues and structural inequities are now known to have resulted in increased risk for infection, severe illness, and death from the virus. The objective of our study was to describe demographic characteristics, clinical presentations, medical interventions and outcomes of pediatric patients with COVID-19 treated at Children’s Hospital of Michigan (CHM), a tertiary care center in urban Detroit, an early hotspot during the initial surge of the SARS-CoV-2 pandemic. Methods. A retrospective chart review was performed of children ≤18 years of age who had polymerase chain reaction (RT-PCR) testing via NP swab or serum IgG antibody testing for SARS-CoV-2 during March 1, 2020–June 30, 2020. Results. Seventy-eight COVID-19 infected children were identified of whom 85.8% (67/78) were from minority populations (African American, Hispanic). Hospitalization rate was 82% (64/78). About 44% (34/78) had an associated comorbidity with asthma and obesity being most common. Although all ages were affected, infants <1 year of age had the highest hospitalization rate (19/64, 30%). In all disease severity categories, dichotomized non-whites had more severe disease by percentage within race/ethnicity than Whites, and also within percent disease severity ( P-value = .197). Overall, 37% of hospitalized patients required intensive care. Conclusions. Extremely high rates of COVID-19 hospitalization and requirement of ICU care were identified in our patient population. Further studies are needed to better understand the contributing factors to this health disparity in disadvantaged communities.


Author(s):  
Hetal Pandya ◽  
Arti Muley ◽  
Roop Gill ◽  
. Jeevana

Aim: Comparison of various scoring systems and to find the better one for predicting the progression of disease in COVID-19 infection. Study Design: Observational. Place and Duration: Department of General medicine, Dhiraj hospital, a tertiary care center, located in Gujarat, India over period of 4 month (May-august 2020). Methodology: We included consecutive 300 adult patients of Asian ethnicity with COVID 19 infection, admitted in the hospital in ICU and Ward, who signed for participation. Various clinical scoring systems evaluated and compared for predictability of progression in COVID-19 infection which included two well-established and widely used systems- CURB-65 and qSOFA and two recent models, one being novel scoring model- CALL score used exclusively for COVID19 patients and other, the modified version of NEWS2 system. These scores were calculated for each confirmed COVID-19 positive patient on admission. WHO clinical disease severity grading was used to stratify patients and as reference for comparison with other scores. Results: Of the 300 patients, 197(65.6%) were male and 103(34.3%) were female with mean age of 49.74±15.69 years. 95(31.6%) patients had co-morbidities, hypertension being the most common (21%) followed by diabetes (14.3%). Using WHO clinical disease severity, 160 (53.3%) patients had mild disease, 68(22.6%) had moderate and 72(24%) had severe disease. The four scoring systems were applied and compared for predictability. NEWS2 system had higher discriminative power(AUC,0.69; 95%CI, 45.5 -72.9%) followed by qSOFA (AUC,0.41; 95%CI, 35.3-48.2%), CALL score had lower discrimination (AUC,0.40; 95%CI, 33.5-46.9%) and CURB-65 had the poor values (AUC,0.35; 95%CI, 29.3-42.1%) in predicting the progression of disease in admitted patients. NEWS2 had sensitivity and specificity of 69.7% and 100% respectively. Conclusion: In this study, four clinical scoring systems were compared on admission and NEWS2 system of risk stratification was found more accurate and better in predicting the disease progression in COVID19 positive patients.


2013 ◽  
Vol 02 (04) ◽  
pp. 245-249
Author(s):  
Rashmi Patnayak ◽  
Amitabh Jena ◽  
Bodagala Vijaylaxmi ◽  
Amancharla Y. Lakshmi ◽  
BCM Prasad ◽  
...  

Abstract Background: Secondary central nervous system (CNS) tumors are common in Western countries, but in Indian literature, scant data are available. With the advent of newer imaging techniques, the confirmatory histopathological diagnosis has become comparatively easier. Hereby, we have analyzed our data from a single tertiary care center in south India. Materials and Methods: In this retrospective study from January 2000 to December 2010, histopathologically diagnosed secondary CNS tumors were reviewed along with clinical, imaging, and relevant immunohistochemical findings. Meningeal, lymphoproliferative, and myeloproliferative tumors and autopsy data were not included in the study group. Results: There were 40 secondary CNS tumors. Male to female ratio was 2.3:1. Age range was wide (28-75 years). Majority of cases were seen in the fourth and fifth decade. Imaging-wise, (computed tomography and magnetic resonance imaging) majority were single lesions (n = 34, 85%). Most commonly, these single lesions were present in the cerebral hemisphere (n = 20, 50%) followed by cerebellum (n = 10, 25%). Adenocarcinoma accounted for maximum number of cases (n = 25, 62.5%) with lungs being the most common primary. Conclusion: We have noted 25% metastatic adenocarcinomas in cerebellar location, which is higher when compared with available world literature. However, we also encountered a good number of cases (30%) due to unknown primary. Though histopathological examination with use of immunohistochemical markers can reliably distinguish primary from secondary CNS tumors in addition to available clinical and imaging data, particularly in developing countries, still a better work-up with an array of immunohistochemical markers and newer imaging modalities is desirable.


2015 ◽  
Vol 72 ◽  
pp. 146-151 ◽  
Author(s):  
Usha Kant Misra ◽  
Jayantee Kalita ◽  
Vinita Elizabeth Mani ◽  
Prashant Singh Chauhan ◽  
Pankaj Kumar

2011 ◽  
Vol 27 (8) ◽  
pp. 1257-1263 ◽  
Author(s):  
Jaya Ruth Asirvatham ◽  
A. Narasimhaiah Deepti ◽  
Rila Chyne ◽  
M. S. N. Prasad ◽  
Ari G. Chacko ◽  
...  

2017 ◽  
Vol 1 (1) ◽  
pp. 61-64
Author(s):  
R.C. Shah ◽  
S. Karki ◽  
S.B. Parajuli ◽  
P. Bhattarai ◽  
P.K. Chowdhary

Introduction Pharmacovigilance is not new to India and has in fact been going on since 1998. Adverse drugs reaction (ADRs) are important causes of morbidity and mortality all over the world. They account for approximately 10-20% of all hospitalized patients. The overall incidence of serious ADRs is 6.7% and that of fatal is 0.32%.Objective The objectives of the study was to find the pattern of adverse drug reactions in patients attending medicine ward of a tertiary care center of New Delhi.Methodology A prospective study was conducted from March 2013 to December 2013. On the basis of WHO-UMC causality assessment algorithm, the incidence and pattern of ADRs were assessed from 300 patients of 18 to 70 years of age. The collected data was entered in Microsoft Excel, Common Terminology Criteria for Adverse Events (CTCAE) and analysed by SPSS.Results The incidence of ADRs was found to be 13.67%. More than one ADRs has been reported from some patients. The gender of the patients has no significance in the occurance of ADRs (p=0.194). Highest number of ADRs were found in gastrointestional system followed by central nervous system. Gastrointestional ADRs were must commonly associated with the uses of antimicrobials. The most frequently seen ADRs were diarrhea, gastritis, abdominal pain followed by nausea and vomiting. Decreased level of consciousness (sedation, drowsiness) followed by dizziness and tremors were the frequent ADRs related to the central nervous systems. Based on WHO-UMC causality assessment algorithm, it was observed that a total of 57 ADRs were possible and 2 were probable. No other causality assessment category was observed.Conclusion The ADRs incidence was common even in a tertiary care center. The Gastrointestional and central nervous system disorder were common. The concern of Pharmacovigilance should be initiated.Birat Journal of Health Sciences 2016 1(1): 61-64


Sign in / Sign up

Export Citation Format

Share Document